Rahul Jandial, M.D., Ph.D.: Pediatric Neurosurgery Humanitarian Missions

March 13, 2018 | Denise Heady

Fourteen years ago, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., began to travel to underserved countries to perform brain surgeries on disadvantaged children.

Continue Reading

What You Should Know About Inherited Breast Cancer

October 25, 2017 | Abe Rosenberg

When Ming was first diagnosed with breast cancer, she knew she'd need surgery. But at her doctor's urging she also took an additional step, scheduling a session with a City of Hope genetic counselor.

For October, here are 31 facts (one a day) about breast cancer

October 24, 2017 | Nicole White and City of Hope

Beyond the pink ribbons, special product fundraisers and the pastel sea of color that marks October, Breast Cancer Awareness Month offers a reason to celebrate and to reflect.

New Treatments and Personalized Care Offer Hope for Stomach Cancer Patients

January 6, 2017 | Samantha Bonar

Although it is uncommon in the U.S., stomach cancer is a serious, often devastating disease. But less than 25 percent of patients who are diagnosed with stomach cancer in the U.S. survive for five years. City of Hope’s physicians and scientists are committed to changing this.

Breast Cancer: 'It's supposed to be a woman's disease'

June 15, 2016 | Stephanie Smith

Male breast cancer is unusual. Breast cancer being cast as “a woman’s disease” means men aren’t checking for it and therefore tend to be diagnosed later. Despite the paltry number of cases, being vigilant is important for men - a lesson Don Hoffman learned the hard way.

Biomarker linked to survival and treatment for BRCA-positive breast cancer patients

June 8, 2016 | H. Chung So

For breast cancer patients with BRCA gene mutations, compounds called poly ADP ribose (or PAR) can help determine treatment response and clinical outcomes.

Study: Increased genetic testing in young breast cancer patients

February 16, 2016 | Valerie Howard

More young breast cancer patients are relying on genetic testing to make informed surgical decisions. According to a new study, published online in JAMA Oncology, nearly all women under 40 years old surveyed in 2013, had undergone BRCA testing within a year of a breast cancer diagnosis, with the vast majority of those who tested positive opting for a double-mastectomy.

Is genetic testing for cancer risk right for you? What you need to know

January 28, 2016 | Travis Marshall

Cancer researchers, like those at City of Hope, have come to understand that mutations in certain genes can mean a higher likelihood of getting certain types of cancer. That’s why genetic testing to identify these mutations has become an important tool in figuring out people’s risk of getting cancer in their lifetimes.

Breast cancer survivor urges young women to consider genetic testing

December 22, 2015 | Valerie Howard

Young women can feel as if they’re invincible, with no need to worry about something as remote as cancer – and certainly no need to worry about how their family members’ health might affect their own. Nothing could be further from the truth, especially for women of Hispanic and African American descent. Women of those ethnic backgrounds are more likely than other women to die from cancer.

ASCO 2015: Clinical trial assesses options for triple-negative breast cancer

May 28, 2015 | Nicole Levine

A clinical trial currently being conducted at City of Hope and elsewhere suggests that researchers are developing improved treatment options for young women with advanced triple-negative breast cancer, a particularly difficult-to-treat disease.

Discovering tools for genetic testing – and teaching others to use them

March 22, 2015 | Nicole White

The understanding of the relationship between genetics and cancer risk continues to grow, with more genetic testing than ever before available to patients. City of Hope leaders have created a program to teach clinicians nationwide and worldwide how to use available genetic testing tools.

Load More